SYK Company Financial Information

Symbol Info
Stryker Corporation (SYK)
Listed Symbol	SYK
Name	Stryker Corporation
Share Info
Annual Info
Latest Fiscal Dividend Per Share	$1.93
Latest Fiscal Date	2018-12-31
Latest Fiscal Revenue	$13,601,000,000
Latest Fiscal EPS	$9.34
Price Info
21 Day Moving Average	$215.1907
21 Day EMA	$214.167980
50 Day Moving Average	$215.8900
50 Day EMA	$213.629620
200 Day EMA	$197.826250
200 Day Moving Average	194.374000
52 Week High	$223.45
52 Week Low	$144.75
52 Week Change	$28.126700
Alpha	0.011463
Beta	0.8056
Standard Deviation	0.046771
R2	0.350276
Periods	60
Share Information
10 Day Average Volume	1,058,165
20 Day Average Volume	1,155,181
30 Day Average Volume	1,103,798
50 Day Average Volume	1,040,309
Outstanding Shares	374,103,607
Float Shares	368,605,892
Percent Float	98.53%
Short Interest	3,445,128
Short Percent Float	0.90%
Short Interest Ratio	3.69
Short Date	2019-09-13
Holders
Institutions	2,161
Institute Holdings Date	2019-09-30
Institute Bought Previous 3 Months	13,390,952
Institute Holdings Percent	-
Institute Sold Previous 3 Months	21,456,906
Insider Holdings Date	2019-08-31
Insider Bought Previous 3 Months	6
Insider Holdings Percent	1.50%
Insider Sold Previous 3 Months	-
Insiders Shares Owned	5,497,715
Price Change
7 Day Price Change	$-1.6800079
7 Day Percent Change	-0.78%
21 Day Price Change	$-6.8584595
21 Day Percent Change	-3.11%
30 Day Price Change	$-3.616272
30 Day Percent Change	-1.66%
Month To Date Price Change	$-2.49
Month To Date Percent	-1.15%
90 Day Price Change	$3.476654
90 Day Percent Change	1.65%
Quarter To Date	$-2.490006
Quarter To Date Percent	-1.15%
180 Day Price Change	$19.450165
180 Day Percent Change	10.01%
200 Day Price Change	$20.124008
200 Day Percent Change	10.39%
Year To Date	$58.251877
Year To Date Percent	37.45%
Profile
Description	Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.
Details
Issue Type	CS
Market Cap	$79,987,092,213
Sec Type	EQS
Auditor	Ernst & Young LLP
Total Shares Outstanding	374,103,607
CEO	Kevin A. Lobo
Employees	36,000
Last Audit	UE
Classification
CIK	0000310764
Industry	Medical Devices
Sector	Healthcare
NAICS	Surgical and Medical Instrument Manufacturing(339112)
Info
Address	2825 Airview Boulevard Kalamazoo, MI 49002
Website	http://www.stryker.com
Facisimile	+1 269 385-1062
Telephone	+1 269 385-2600
Email	info@amstock.com
Key Ratios
Profitability
EBIT Margin	18.00
EBITDA Margin	23.3
Pre-Tax Profit Margin	16.1
Profit Margin Cont	27.00
Gross Margin	65.30
Profit Margin TOT	27.00
Income Statements
Revenue	$10,962,000,000
Revenue Per Share	$29.3020
Revenue 3 Years	$3.22
Revenue 5 Years	$6.05
Valuation Measures
PE Ratio	22.40
Enterprise Value	$87,592,610,194
Price To Sales	7.296761
Price To Free Cash	-72.8
PE High Last 5 Years	78.6
Price To Book	6.6
Price To Cash Flow	31.9
PE Low Last 5 Years	22.9
Price To Tangible Book	-78
Financial Strength
Total Debt To Equity	0.7
Int Coverage	-
Current Ratio	2.1
Leverage Ratio	2.3
Quick Ratio	1.1
Long Term Debt To Capital	0.40
Assets
Receivables Turnover	2.0
Invoice Turnover	1.50
Assets Turnover	0.20
Management Effectiveness
Return Assets	14.82
Return On Equity	33.17
Return On Capital	19.13
Dividends
Dividend 3 Years	$9.09
Dividend 5 Years	$10.38
Ex Dividend Date	2019-09-27 00:00:00.0
Dividend Rate	$2.08
Dividend Yield	0.97%
Payment Type	Cash